One hour with …… Pierre Rocheteau, Co-Founder and CEO, Olgram, France
🕑 Thursday, January14th @ 14:00 CET
Live interview followed by questions from the online audience
Exploring the marine environment in order to find unique solutions to eliminate the origin of the recalcitrance of bacterial infectious diseases.
🆓 For all Members of BioMarine Community (100 partipants only). If you are not a member yet, free sign-up HERE
❓ How enter the webinar : Log-in on biomarine.org, click on the “One hour with” tab on the top menu. The link will be following the “One hour with” of the day 15 min prior the beginning. You can post your questions and the moderator will manage the Q&A part.
🆘 Any question or need of a certificate of attendance? email@example.com.
🔎 More information on OLGRAM:
Olgram is a biotechnology company fighting against chronic infectious diseases by developing two programs:
1) A new immunostimulatory drug thanks to a molecule found in algae
2) A new class of anti-infectives to kill persistent bacteria
In June 2019: the project is awarded with grand laureate I-Lab price of the BPI France. The project MAPOLI (Marine Polysaccharides for Immunity) is granted Grand Lauréat for the 2019 edition of the i-Lab competition.
Olgram is the pharmaceutical branch of the Amadeite group. Amadeite / Olmix has dedicated itself to the emergence of a sustainable agriculture. Pierre Rocheteau is the co-Founder and CEO of Olgram : "We have found and patented in algae a new molecule able to stimulate the immune system in immunodepressed injured models with unique biological and clinical properties that could avoid the nosocomial infections, providing doctors with a new therapeutic tool that will be life saving for hundreds of thousands of patients every year".